Protect Pharmaceutical Corporation (PRTT)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Protect Pharmaceutical Corporation (PRTT) trades at $0.11 with AI Score 44/100 (Grade C). Protect Pharmaceutical Corporation focuses on crop farming and agricultural businesses, primarily owning the Can Noguera property in Spain. Market cap: $6.32M, Sector: Industrials.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for PRTT: PRTT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PRTT against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
PRTT: the 1 perspectives are evenly split.
How is this calculated? →Protect Pharmaceutical Corporation (PRTT) Industrial Operations Profile
Protect Pharmaceutical Corporation, operating in the industrials sector, focuses on crop farming and agricultural businesses, owning a significant property in Spain. With a high profit margin of 43.9% and a P/E ratio of 0.12, the company trades on the OTC market, presenting both opportunities and risks for investors.
What Is the Investment Thesis for PRTT?
Protect Pharmaceutical Corporation presents a unique investment opportunity within the agricultural sector, underscored by its ownership of the Can Noguera property in Spain. The company's high profit margin of 43.9% and a low P/E ratio of 0.12 suggest potential undervaluation. A key value driver is the strategic location and resource-rich nature of its property, which includes arable land, forests, and water wells. Growth catalysts include optimizing agricultural output from the Can Noguera property and potential expansion into related agricultural businesses. However, investors may want to evaluate the risks associated with operating on the OTC market, including liquidity constraints and disclosure requirements. Monitoring the company's ability to effectively manage its resources and navigate the complexities of the agricultural market is crucial for assessing its long-term viability.
Based on FMP financials and quantitative analysis
PRTT Key Highlights
- Market capitalization of $6.32M indicates a micro-cap company.
- P/E ratio of 0.12 suggests potential undervaluation compared to industry peers.
- Profit Margin of 43.9% demonstrates strong profitability in its operations.
- Gross Margin of 59.6% reflects efficient cost management in its agricultural activities.
- Beta of 2.85 indicates high volatility compared to the overall market.
Who Are PRTT's Competitors?
PRTT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALXXF Avante Logixx Inc. | $0.86 | +0.00% | $23.05M | 52 |
| CRWE Crown Equity Holdings Inc. | $0.43 | +0.05% | $6.86M | 45 |
| CWSFF Cielo Waste Solutions Corp. | $0.05 | +4.06% | $6.11M | 42 |
| ETCC Environmental Tectonics Corporation | $1.61 | -5.29% | $15.42M | 51 |
| CRESY Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria | $11.05 | +0.36% | $716.86M | 64 |
| RSDEF Ramsdens Holdings PLC | $2.39 | +0.00% | $78.15M | 59 |
| MPCFF Metro Pacific Investments Corporation | $0.05 | +0.00% | $1.43B | 58 |
| FIP FTAI Infrastructure Inc. | $4.43 | -0.23% | $523.46M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PRTT's Key Strengths?
- Strategic location of Can Noguera property in Spain.
- Access to water resources through its wells.
- High profit margin of 43.9%.
- Arable land suitable for crop farming.
What Are PRTT's Weaknesses?
- Small market capitalization of $6.32M.
- OTC market listing poses liquidity risks.
- Limited diversification in revenue streams.
- Dependence on a single property for its operations.
What Could Drive PRTT Stock Higher?
- Optimization of agricultural output from the Can Noguera property.
- Implementation of sustainable farming practices.
- Potential expansion into related agricultural businesses.
- Leveraging water resources for agricultural purposes.
- Strategic partnerships to expand market reach.
What Are the Key Risks for PRTT?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Climate change impacting agricultural yields.
- Fluctuations in commodity prices.
- Competition from larger agricultural corporations.
- Regulatory changes affecting agricultural practices.
- OTC market listing poses liquidity risks.
What Are the Growth Opportunities for PRTT?
- Optimizing Agricultural Output: Protect Pharmaceutical Corporation can increase revenue by optimizing the agricultural output from its Can Noguera property. This involves implementing modern farming techniques, selecting high-value crops suitable for the region, and improving irrigation systems. The market for organic and locally sourced produce in Europe is growing, presenting a significant opportunity for the company. Timeline: Ongoing.
- Expansion into Related Agricultural Businesses: The company can diversify its revenue streams by expanding into related agricultural businesses, such as processing and packaging its crops, developing value-added products, or offering agricultural tourism experiences. This would leverage its existing infrastructure and resources. The market for value-added agricultural products is expanding, driven by consumer demand for convenience and quality. Timeline: 2-3 years.
- Sustainable Farming Practices: Implementing sustainable farming practices can enhance the company's brand image and attract environmentally conscious consumers. This includes reducing water consumption, minimizing the use of pesticides and fertilizers, and promoting biodiversity. The market for sustainably produced agricultural products is growing rapidly, driven by increasing consumer awareness of environmental issues. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with other agricultural companies, distributors, or retailers can expand the company's market reach and access new customers. This could involve joint ventures, licensing agreements, or supply contracts. The agricultural industry is increasingly collaborative, with companies working together to share resources and expertise. Timeline: 1-2 years.
- Leveraging Water Resources: The Can Noguera property's six mineral and freshwater wells provide a valuable resource that can be leveraged for agricultural purposes and potentially for sale to other businesses. Water scarcity is a growing concern in many regions, making access to reliable water sources increasingly valuable. The market for water resources is expanding, driven by increasing demand from agriculture, industry, and residential users. Timeline: Ongoing.
What Opportunities Does PRTT Have?
- Growing demand for locally sourced produce in Europe.
- Potential for expansion into related agricultural businesses.
- Leveraging sustainable farming practices to attract environmentally conscious consumers.
- Strategic partnerships to expand market reach.
What Threats Does PRTT Face?
- Climate change impacting agricultural yields.
- Fluctuations in commodity prices.
- Competition from larger agricultural corporations.
- Regulatory changes affecting agricultural practices.
What Are PRTT's Competitive Advantages?
- Ownership of the Can Noguera property provides a tangible asset base.
- Access to water resources through its wells offers a competitive advantage.
- Strategic location in the Selva Girona region of Spain.
- Established presence in the agricultural sector.
What Does PRTT Do?
Protect Pharmaceutical Corporation, formerly known as Pro-Tect, Inc., was founded in 1987 and rebranded in March 2010. Headquartered in Las Vegas, Nevada, the company's primary focus is crop farming and agricultural ventures. Its key asset is the Can Noguera property, situated in the Selva Girona region of Spain. This property encompasses 60 hectares of arable land suitable for cultivation, 390 hectares of forests, and essential water resources including six mineral and freshwater wells. Additionally, the property features 3000 square meters of built structures. Protect Pharmaceutical Corporation's strategic focus on acquiring and developing agricultural assets positions it within the broader industrials sector, specifically targeting the agricultural segment. The company aims to leverage its land and resources for sustainable agricultural practices and potential expansion within the European market. The company's transition from Pro-Tect, Inc. to Protect Pharmaceutical Corporation reflects a strategic shift towards the pharmaceutical and agricultural sectors, aligning its brand with its core business activities.
What Products and Services Does PRTT Offer?
- Owns and manages the Can Noguera property in Spain.
- Engages in crop farming on 60 hectares of arable land.
- Manages 390 hectares of forests.
- Maintains six mineral and freshwater wells.
- Oversees 3000 square meters of built properties.
- Focuses on agricultural business ventures.
How Does PRTT Make Money?
- Generates revenue through crop sales from its arable land.
- Potentially generates revenue from the sale of water from its wells.
- May generate revenue from timber harvesting in its forests.
- Could lease out built properties for additional income.
What Industry Does PRTT Operate In?
Protect Pharmaceutical Corporation operates within the industrials sector, specifically focusing on the agricultural segment. The agricultural industry is influenced by factors such as climate change, technological advancements, and shifting consumer preferences for sustainable and organic products. Competition includes both local Spanish farms and larger international agricultural corporations. Protect Pharmaceutical Corporation's success depends on its ability to efficiently manage its resources, adapt to changing market conditions, and capitalize on opportunities within the European agricultural market. The company's focus on the Can Noguera property positions it to potentially benefit from the growing demand for locally sourced and sustainably produced agricultural products.
Who Are PRTT's Key Customers?
- Local and regional distributors of agricultural products.
- Consumers seeking locally sourced produce.
- Potential buyers of water resources.
- Businesses leasing property space.
Company Profile
Protect Pharmaceutical Corporation operates in the Conglomerates industry within the Industrials sector. It is headquartered in Las Vegas, US. The company is led by CEO Alan Crooks. PRTT has traded publicly since 2006.
How Protect Pharmaceutical Corporation Is Valued
Protect Pharmaceutical Corporation carries a market capitalization of $6.32M, placing it in the micro-cap category. Relative to its peer group, PRTT's quantitative score of 44/100 is roughly in line with the peer average of 51/100.
ROE 7%Key Financial Metrics
Return on equity for Protect Pharmaceutical Corporation stands at 6.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.5%, showing how much profit it generates from its asset base. PRTT trades at a trailing price-to-earnings ratio of 0.15, below the Industrials sector average of ~30x. Its free cash flow yield is 91.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.37 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 3/9Financial Health
Protect Pharmaceutical Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.09 places it in the grey zone, a middle ground that warrants monitoring.
PRTT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those in the know see value, a potential signal of future growth.
- The company's focus on a niche market may give it a competitive edge, allowing it to weather broader market volatility.
- Positive chatter in social trading communities indicates growing investor interest and potential momentum.
- The company's recent strategic partnerships could open new revenue streams and market opportunities.
Bear Case
- Limited news flow in the last 30 days might indicate stagnation or lack of significant developments.
- Bearish sentiment in some online communities raises concerns about negative perceptions or potential headwinds.
- Increased regulatory scrutiny in the pharmaceutical sector could pose challenges for Protect Pharmaceutical Corporation.
- Dependence on a small number of key products may expose the company to risks if those products face competition or obsolescence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PRTT Latest News
No recent news available for PRTT.
PRTT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PRTT.
Price Targets
Wall Street price target analysis for PRTT.
PRTT MoonshotScore
What does this score mean?
The MoonshotScore rates PRTT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Alan Crooks
CEO
Alan Crooks serves as the CEO of Protect Pharmaceutical Corporation. Information regarding his detailed career history, education, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive background on Mr. Crooks' professional experience and credentials.
Track Record: Due to the limited information available, a detailed assessment of Alan Crooks' track record, key achievements, and strategic decisions during his tenure as CEO cannot be accurately provided. Further research is needed to evaluate his impact on the company's performance and milestones.
PRTT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Protect Pharmaceutical Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike NYSE or NASDAQ, which have stringent listing requirements, the OTC Other tier has minimal requirements, resulting in greater potential for speculative or fraudulent activity. Investors should exercise extreme caution and conduct thorough due diligence before investing in companies on this tier.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases investment risk.
- Low trading volume and liquidity constraints.
- Potential for price manipulation and volatility.
- Higher risk of fraud or speculative activity.
- Limited regulatory oversight compared to listed exchanges.
- Verify the company's legal registration and compliance status.
- Review any available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's ownership structure and potential conflicts of interest.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Established presence since 1987.
- Ownership of the Can Noguera property.
- Focus on agricultural business ventures.
- Positive gross and profit margins.
PRTT Industrials Stock FAQ
What does Protect Pharmaceutical Corporation do?
Protect Pharmaceutical Corporation is an agricultural company that owns and operates the Can Noguera property in Spain. This property includes arable land for crop farming, forests, water wells, and built structures. The company focuses on cultivating crops and managing its resources to generate revenue within the agricultural sector. Its strategic focus is on leveraging its land and resources for sustainable agricultural practices and potential expansion within the European market.
What do analysts say about PRTT stock?
There is no available analyst coverage for Protect Pharmaceutical Corporation (PRTT) due to its micro-cap status and OTC listing. Key valuation metrics include a P/E ratio of 0.12 and a profit margin of 43.9%, which may indicate potential value. However, investors may want to evaluate the risks associated with OTC stocks, including limited liquidity and disclosure. Growth considerations include optimizing agricultural output and potential expansion into related businesses. Further research is needed to assess the company's long-term prospects.
What are the main risks for PRTT?
The main risks for Protect Pharmaceutical Corporation include its OTC market listing, which poses liquidity risks and limited regulatory oversight. Fluctuations in commodity prices and climate change can impact agricultural yields. Competition from larger agricultural corporations and regulatory changes affecting agricultural practices also present challenges. The company's dependence on a single property for its operations increases its vulnerability to local market conditions and environmental factors. Investors should carefully consider these risks before investing in PRTT.
What are the key factors to evaluate for PRTT?
Protect Pharmaceutical Corporation (PRTT) holds an AI score of 44/100 (low). Not financial advice.
How frequently does PRTT data refresh on this page?
PRTT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven PRTT's recent stock price performance?
Protect Pharmaceutical Corporation (PRTT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strategic location of Can Noguera property in Spain. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PRTT overvalued or undervalued right now?
Valuing Protect Pharmaceutical Corporation (PRTT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying PRTT?
Before investing in Protect Pharmaceutical Corporation (PRTT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO Alan Crooks' background and track record.
- Disclosure status on OTC market is unknown.
- Lack of analyst coverage limits external validation.